A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial resultsMatthew Winter, Janet E. Brown, Jessica Kendall et al.|Journal of bone oncology|2022Cited by 10